Stephen D. Hursting, PhD, MPH
Professor of Nutrition
hursting@email.unc.edu
704-250-5059
Lab Website
View CV
Dr. Hursting is Professor of Nutrition at the UNC Nutrition Research Institute in Kannapolis, NC. He is also Professor in the Department of Nutrition and the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. An international leader in the area of nutrition, obesity, metabolism and cancer, his lab focuses on the molecular and metabolic mechanisms underlying obesity-cancer associations, and the impact of obesity- energy balance modulation (eg, calorie restriction and exercise) or pharmacologic agents on cancer development, progression, and responses to chemotherapy. Primarily using genetically engineered mouse models of breast cancer (recently in parallel with several clinical trials), colon cancer and pancreatic cancer, Dr. Hursting has identified the IGF1/Akt/mTOR and NF-kB signaling pathways as key targets for breaking the obesity-cancer link. His publications establish causal links between obesity, cancer and several systemic factors (including IGF-1, insulin, leptin and IL-6) and components of their downstream signaling pathways (including mTOR and NF-kb).
Prior to joining the UNC faculty in 2014, Dr. Hursting was Professor and Chair of the Department of Nutritional Sciences at the University of Texas (UT) at Austin, the McKean-Love Endowed Chair of Nutritional, Molecular and Cellular Sciences in the UT College of Natural Sciences, and Professor of Molecular Carcinogenesis at the UT-MD Anderson Cancer Center (2005-14). Dr. Hursting earned a BA in biology from Earlham College and a PhD in nutritional biochemistry and an MPH in nutritional epidemiology from the University of North Carolina at Chapel Hill. He also completed postdoctoral training in molecular biology and cancer prevention as a Cancer Prevention Fellow at the National Cancer Institute (NCI).
Show More
Hursting’s Team



Publications
2020
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy.
2019
2018
Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.
Research Strategies for Nutritional and Physical Activity Epidemiology and Cancer Prevention.
Translating Mechanism-Based Strategies to Break the Obesity-Cancer Link: A Narrative Review.
2017
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic Factors.
When less may be more: calorie restriction and response to cancer therapy.
Energy balance and obesity: what are the main drivers?
Metabolic Reprogramming by Folate Restriction Leads to a Less Aggressive Cancer Phenotype.
2016
Body Fatness and Cancer–Viewpoint of the IARC Working Group.
Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.